{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T10:28:15Z","timestamp":1783247295734,"version":"3.54.6"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["FR-28"],"award-info":[{"award-number":["FR-28"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["FR-945"],"award-info":[{"award-number":["FR-945"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["A\/Brisbane\/59\/2007"],"award-info":[{"award-number":["A\/Brisbane\/59\/2007"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["NR-43784"],"award-info":[{"award-number":["NR-43784"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["B\/Florida\/4\/2006"],"award-info":[{"award-number":["B\/Florida\/4\/2006"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["A\/Minnesota\/11\/2010"],"award-info":[{"award-number":["A\/Minnesota\/11\/2010"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["NR-19236"],"award-info":[{"award-number":["NR-19236"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["A\/Switzerland\/2013 X-247"],"award-info":[{"award-number":["A\/Switzerland\/2013 X-247"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["A\/Brisbane\/10\/2007"],"award-info":[{"award-number":["A\/Brisbane\/10\/2007"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["FR-1366"],"award-info":[{"award-number":["FR-1366"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["A\/California\/04\/2009"],"award-info":[{"award-number":["A\/California\/04\/2009"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["NR-19234"],"award-info":[{"award-number":["NR-19234"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI154656"],"award-info":[{"award-number":["AI154656"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002581","name":"School of Medicine, CHA University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002573","name":"Yonsei University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002573","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.virol.2024.110097","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T02:48:22Z","timestamp":1714013302000},"page":"110097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets"],"prefix":"10.1016","volume":"595","author":[{"given":"Ki-Hye","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noopur","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeeva","family":"Subbiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya Sekhar","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannatul Ruhan","family":"Raha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Grovenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Hyun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6198-331X","authenticated-orcid":false,"given":"Sang-Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2024.110097_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001401","article-title":"Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine","volume":"3","author":"Baras","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2024.110097_bib2","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1128\/JVI.01035-10","article-title":"Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets","volume":"84","author":"Bosch","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110097_bib3","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.vaccine.2019.01.068","article-title":"Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay","volume":"37","author":"Chae","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110097_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02810-18","article-title":"Design of nanoparticulate group 2 influenza virus hemagglutinin stem antigens that activate unmutated ancestor B cell receptors of broadly neutralizing antibody lineages","volume":"10","author":"Corbett","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.virol.2024.110097_bib5","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/infdis\/jis935","article-title":"Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase","volume":"207","author":"Couch","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2024.110097_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41467-017-02725-4","article-title":"Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses","volume":"9","author":"Deng","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2024.110097_bib7","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMc1313186","article-title":"A recombinant viruslike particle influenza A (H7N9) vaccine","volume":"369","author":"Fries","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2024.110097_bib8","doi-asserted-by":"crossref","DOI":"10.3791\/54573-v","article-title":"Measuring influenza neuraminidase inhibition antibody titers by enzyme-linked lectin assay","author":"Gao","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.virol.2024.110097_bib9","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110097_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/irv.12786","article-title":"Assessment of the benefits of seasonal influenza vaccination: elements of a framework to interpret estimates of vaccine effectiveness and support robust decision-making and communication","volume":"15","author":"Hollingsworth","year":"2021","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.virol.2024.110097_bib11","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.virol.2024.110097_bib12","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0264-410X(01)00490-X","article-title":"Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition","volume":"20","author":"Johansson","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110097_bib13","doi-asserted-by":"crossref","first-page":"10945","DOI":"10.1128\/JVI.05406-11","article-title":"H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans","volume":"85","author":"Khurana","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110097_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010755","article-title":"Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle","volume":"18","author":"Kim","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2024.110097_bib15","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/mt.2014.33","article-title":"Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection","volume":"22","author":"Kim","year":"2014","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.virol.2024.110097_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/mt.2012.246","article-title":"Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus","volume":"21","author":"Kim","year":"2013","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.virol.2024.110097_bib17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.antiviral.2018.08.017","article-title":"Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice","volume":"158","author":"Kolpe","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2024.110097_bib18","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/biot.201400393","article-title":"Emerging influenza viruses and the prospect of a universal influenza virus vaccine","volume":"10","author":"Krammer","year":"2015","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.virol.2024.110097_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02332-17","article-title":"NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines?","volume":"9","author":"Krammer","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.virol.2024.110097_bib20","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1128\/JVI.03004-13","article-title":"Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets","volume":"88","author":"Krammer","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110097_bib21","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/JVI.03183-13","article-title":"H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge","volume":"88","author":"Krammer","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110097_bib22","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/infdis\/jiy711","article-title":"Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain","volume":"219","author":"Krammer","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2024.110097_bib23","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110097_bib24","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2024.110097_bib25","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1016\/j.vaccine.2011.07.099","article-title":"Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico","volume":"29","author":"Lopez-Macias","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110097_bib26","doi-asserted-by":"crossref","first-page":"E2514","DOI":"10.1073\/pnas.1402766111","article-title":"Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection","volume":"111","author":"Mallajosyula","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2024.110097_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","author":"Margine","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110097_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00417-16","article-title":"Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A\/H1N1 virus healthy human challenge model","volume":"7","author":"Memoli","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.virol.2024.110097_bib29","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to influenza virus neuraminidase: an independent correlate of protection","volume":"212","author":"Monto","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2024.110097_bib30","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.vaccine.2015.12.023","article-title":"Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets","volume":"34","author":"Music","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110097_bib31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/ni.3684","article-title":"Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins","volume":"18","author":"Nachbagauer","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2024.110097_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41541-017-0026-4","article-title":"A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies","volume":"2","author":"Nachbagauer","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.virol.2024.110097_bib33","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.02481-15","article-title":"Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets","volume":"90","author":"Nachbagauer","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2024.110097_bib34","article-title":"Neutralizing antibodies targeting the conserved stem region of influenza hemagglutinin","volume":"8","author":"Nath Neerukonda","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2024.110097_bib35","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1038\/s41467-022-32149-8","article-title":"Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses","volume":"13","author":"Pardi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2024.110097_bib36","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1016\/j.vaccine.2009.08.053","article-title":"Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses","volume":"27","author":"Price","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2024.110097_bib37","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hygiene"},{"key":"10.1016\/j.virol.2024.110097_bib38","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa2103055","article-title":"Efficacy of NVX-CoV2373 covid-19 vaccine against the B.1.351 variant","volume":"384","author":"Shinde","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2024.110097_bib39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.virol.2017.06.006","article-title":"Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets","volume":"509","author":"Smith","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.virol.2024.110097_bib40","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1073\/pnas.1012199108","article-title":"Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus","volume":"108","author":"Song","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2024.110097_bib41","article-title":"Thermostable engineered H1 hemagglutinin stem with M2e epitopes provides broad cross-protection against group1 and 2 influenza A viruses","author":"Subbiah","year":"2022","journal-title":"Mol. Ther. MCD Pre-proofs"},{"key":"10.1016\/j.virol.2024.110097_bib42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41541-022-00498-6","article-title":"A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine","volume":"7","author":"Subbiah","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.virol.2024.110097_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41541-017-0036-2","article-title":"Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines","volume":"2","author":"Sutton","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.virol.2024.110097_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02500-16","article-title":"Hierarchical and redundant roles of activating FcgammaRs in protection against influenza disease by m2e-specific IgG1 and IgG2a antibodies","volume":"91","author":"Van den Hoecke","year":"2017","journal-title":"J. Virol."},{"issue":"Suppl. l","key":"10.1016\/j.virol.2024.110097_bib45","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jip.2011.05.004","article-title":"Large-scale production and purification of VLP-based vaccines","volume":"107","author":"Vicente","year":"2011","journal-title":"J. Invertebr. Pathol."},{"key":"10.1016\/j.virol.2024.110097_bib46","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2024.110097_bib47","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/ciw635","article-title":"2014-2015 influenza vaccine effectiveness in the United States by vaccine Type","volume":"63","author":"Zimmerman","year":"2016","journal-title":"Clin. Infect. Dis."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224001181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224001181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:19:41Z","timestamp":1751383181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682224001181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":47,"alternative-id":["S0042682224001181"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2024.110097","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2024.110097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110097"}}